Euro zone consumer staples stocks are in focus after France reported a harmonized inflation rate of 2.4% year on year for July, above the 2.1% forecast. Higher than expected inflation can affect everything from shopper behavior to company cost structures, and it often feeds into expectations for European Central Bank policy. For investors, this creates both potential risks and openings as market sentiment adjusts. This article walks through 3 consumer staples stocks from the screener that appear closely exposed to this inflation story and explains why some investors may see them as potential beneficiaries of the current backdrop.
Overview: Glanbia is a global nutrition company that sells sports and lifestyle nutrition products, cheese, and dairy and non dairy ingredients, along with vitamin and mineral premixes, reaching consumers through retailers, gyms, and online channels worldwide.
Operations: Glanbia generates most of its $3.95b in annual revenue from Performance Nutrition at $1.80b and Dairy Nutrition at $1.57b, with Health & Nutrition contributing $631m.
Market Cap: €5.46b
Glanbia stands out in this inflation focused consumer staples screen because it sits at the intersection of everyday dairy ingredients and higher margin performance and health products, which can support pricing power when input costs are rising. Analysts expect earnings to grow in the coming years even though revenue growth is described as more modest, with cost savings programs and a sharper focus on higher margin segments highlighted as potential supports. At the same time, the stock trades on a relatively high P/E and has had a large one off loss of $122.8m, while funding relies on external borrowing and the dividend record is uneven. If you want to see how these positives and pressure points compare, the detailed narrative and forecasts provide additional context.
Glanbia’s mix of everyday dairy and higher margin performance nutrition could be masking a very different earnings path than its headline P/E suggests. Get the full picture in the 3 key rewards and 2 important warning signs
Overview: Savencia is a French dairy group that produces and markets branded cheese, butter, cream and dairy ingredients for both supermarkets and food service customers in France, wider Europe and international markets.
Operations: Savencia generates most of its revenue from Cheese Products at about €4.02b and Other Dairy Products at about €3.18b, with smaller contributions from other activities and intra group eliminations.
Market Cap: €818.24m
For investors watching how higher French inflation affects everyday spending, Savencia offers direct exposure to essential food products on supermarket shelves. The stock is priced below one estimate of fair value and trades on a lower P/E than many peers, which may appeal to value focused investors. However, current profitability is thin, recent earnings fell due to one off items and returns on equity are low, so there is execution risk if cost pressures persist. The tension between valuation, French inflation sensitivity and modest margins is what makes Savencia worth a closer look.
Valuation on Savencia looks like it is lagging its supermarket presence, which could mean the market has not fully priced the balance of thin margins and French inflation exposure. See how that trade off stacks up in the analysis report for Savencia
Overview: Miko is a long established Belgian coffee group that roasts and sells coffee under the Miko brand, supplies related products like milk, sugar and cookies, and installs and services coffee and vending machines across Europe and Australia.
Operations: Miko generates all of its €312.23m in revenue from the coffee service sector, with the Netherlands, Sweden/Denmark/Norway and Belgium among its largest markets.
Market Cap: €81.97m
Investors looking for a consumer staples stock tied directly to everyday consumption may find Miko interesting. The company is priced well below one estimate of fair value, while earnings growth has been strong and supported recently by higher margins, tighter cost control and new product lines aligned with value seeking shoppers. At the same time, returns on equity remain modest, funding leans on external borrowing and the dividend record is uneven, so income focused investors may be more cautious. With French and euro zone inflation running hotter than expected and coffee consumption remaining habitual, the real story is how this mix of earnings momentum, small cap risk and inflation sensitive demand fits together for Miko.
Miko’s earnings momentum and small cap status could be masking a very different risk reward profile than its size suggests. See how that story fits together in the 3 key rewards and 1 important warning sign
The three euro zone consumer staples stocks in this article are only a starting point, with the full Consumer Staples Stocks screener surfacing four more companies that each have their own inflation and essential goods narratives. Use Simply Wall St to identify and analyze the specific catalysts, financial traits and storylines that matter most to you so you can focus on the highest conviction consumer staples ideas.
If Glanbia or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Fresh stock ideas can move from quiet to crowded quickly. Catch the next wave of breakout momentum while it matters and before the best entry points get caught. Act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com